This HTML5 document contains 203 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37427140
rdf:type
wikibase:Item
schema:description
scientific article published on 23 May 2016 գիտական հոդված հրատարակված 2016 թվականի մայիսի 23-ին επιστημονικό άρθρο научни чланак article scientific 2016年学术文章 vetenskaplig artikel 2016年學術文章 article científic 2016년 논문 2016年学术文章 artikull shkencor wissenschaftlicher Artikel 2016年學術文章 vitskapeleg artikkel مقالة علمية نشرت في 23 مايو 2016 2016年學術文章 מאמר מדעי مقالهٔ علمی ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico 2016年の論文 mokslinis straipsnis artigo científico (publicado na 2016) tudományos cikk 2016年学术文章 научни чланак vědecký článek vitenskapelig artikkel наукова стаття, опублікована в травні 2016 мақолаи илмӣ บทความทางวิทยาศาสตร์ 2016年学术文章 научна статия 2016年學術文章 artículu científicu espublizáu en 2016 tieteellinen artikkeli scienca artikolo vedecký článok artikulong pang-agham 2016年学术文章 articol științific wetenschappelijk artikel article scientifique publié en 2016 سائنسی مضمون 2016年學術文章 2016 nî lūn-bûn teaduslik artikkel videnskabelig artikel (udgivet 2016) bài báo khoa học 2016年學術文章 artykuł naukowy სამეცნიერო სტატია bilimsel makale artigo científico (publicado na 2016) мақолаи илмӣ artículo científico publicado en 2016 2016 മെയ് 23 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം научная статья articolo scientifico naučni članak
p:P577
wds:Q37427140-B66D8CE6-76C6-4CD9-B77A-16735CB8C30F
wdt:P577
2016-05-23T00:00:00Z
p:P407
wds:Q37427140-CE02432E-37EB-48A9-A85C-EABB59BCCBF2
wdt:P407
wd:Q1860
p:P2860
wds:Q37427140-F4A7E722-EE2A-4FC1-84CA-EF6364BF5339 wds:Q37427140-F90AD0B3-8FE3-4335-AC37-55D1F6A8A2FD wds:Q37427140-228F53F3-BE67-41C8-B4EB-461D7D2F9AD5 wds:Q37427140-23CB1F2F-A118-4DE8-AA17-6399EAD7559A wds:Q37427140-2A19089C-A019-42C6-9515-0A38BF848EBB wds:Q37427140-1E7E041E-FFD1-4FB3-9E8E-2C411045BD32 wds:Q37427140-20F8EAD9-933A-4F84-8141-2B6C545BE8AB wds:Q37427140-074D7FAE-F3F8-4ABE-8BEC-4178F7195F68 wds:Q37427140-46FB909E-9F70-486A-A2BE-293B11BD1ABE wds:Q37427140-48C1F459-0ED7-441C-B625-AEFF928EFF14 wds:Q37427140-493C68A0-1957-4BCA-87B4-52C164B6DC46 wds:Q37427140-4F81F547-08D4-4713-B0D0-B5F703E2EAA6 wds:Q37427140-408BA141-E3B1-48F5-A6D2-13A792F7E5C9 wds:Q37427140-44F21D2E-3BFE-46B7-9998-BF1FCC66EBC2 wds:Q37427140-462B6467-0414-4B92-8200-8F62D4F76B4F wds:Q37427140-38CDF56F-BAB8-4816-9A9A-1FF0ACF9766C wds:Q37427140-3FFAC055-ACDC-440A-82E5-70B70BA1C7CB wds:Q37427140-97F8EE2D-9DDF-4FC9-A07D-F5C69D076B01 wds:Q37427140-76AF84D4-DC67-45F1-9A87-D964B993BB72 wds:Q37427140-76EC3C77-4B23-45AD-8932-C58AE352CC3C wds:Q37427140-72ADEC3D-1CE5-4197-BAB9-B1A65BE57C3B wds:Q37427140-73C8D2F6-FAEE-4072-862D-8066FAC6797C wds:Q37427140-743B29EA-2483-4761-A06B-7D8C3EB37B1A wds:Q37427140-5FA3192A-9127-45DE-8443-A6A8AB250E05 wds:Q37427140-DDDB7A0E-34BC-488D-B668-A8DB4597781A wds:Q37427140-DE703A14-D80F-4AE1-AE9E-9211E60885EB wds:Q37427140-E2F50CD6-C049-4639-A249-200728B00129 wds:Q37427140-CF0C9AE1-FDC0-40CB-AA68-BF897A4F09CE wds:Q37427140-D27D910F-8CC3-4465-976F-9014052ECC04 wds:Q37427140-BF64797E-E198-4AC6-8CEA-248E5283DA08 wds:Q37427140-CD826CC7-6C67-48FB-ABBC-49F9EC065E64 wds:Q37427140-983935D7-52D0-4278-99C2-F829F7983ED0 wds:Q37427140-B0940722-0CCC-40F3-B5C7-C3C69B89D5E7 wds:Q37427140-FF7F1D71-141B-45AC-ABBC-5D75026720EB wds:Q37427140-E4B8F653-0790-4CE3-9EF5-D01B1AEA88C5 wds:Q37427140-F04D68D6-0ED5-478A-9D56-ECE01E31CF67
wdt:P2860
wd:Q43607483 wd:Q46419894 wd:Q34310190 wd:Q35849776 wd:Q37618888 wd:Q44270173 wd:Q34747837 wd:Q43043759 wd:Q53178586 wd:Q43102333 wd:Q41668621 wd:Q35565658 wd:Q33402939 wd:Q36026747 wd:Q55966524 wd:Q34567629 wd:Q44369402 wd:Q44611047 wd:Q33398716 wd:Q35902738 wd:Q37635598 wd:Q41768439 wd:Q38128723 wd:Q35873909 wd:Q39814801 wd:Q54551498 wd:Q54508109 wd:Q79950167 wd:Q38568955 wd:Q34634826 wd:Q35300745 wd:Q44242768 wd:Q83465806 wd:Q35694453 wd:Q35194464 wd:Q57731587
p:P2093
wds:Q37427140-7658EECE-012E-4775-80C8-B54D95882C60 wds:Q37427140-719035ED-89CE-4BA9-B54B-D782C80C2136 wds:Q37427140-16BDA575-34F2-4E92-A7F3-02FF4ED6E36F wds:Q37427140-1A7A4B80-184A-41CE-A383-B9F51CB3BD64
wdt:P2093
Jiří Mayer Neil P Shah Luis Casanova George Manos
rdfs:label
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
skos:prefLabel
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
schema:name
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
p:P50
wds:Q37427140-2B754474-4A54-4CE4-8742-F53F4D97B97F wds:Q37427140-3E1A1E4C-07F6-4C1C-A722-FE28FD13190E wds:Q37427140-504DC8B1-97B0-4718-9104-0CEB081DA5C6 wds:Q37427140-0F01259B-8BB3-437F-A923-4A555437177A wds:Q37427140-B87D9A8A-20D2-43D7-8B1C-F7D647F0C021 wds:Q37427140-CEC7A07D-3112-49C5-89B3-E1234B051B1C wds:Q37427140-78031B1B-F56A-4972-8310-39E9D68FDCC1 wds:Q37427140-91628078-1DFC-4953-9D03-E218A2E4028C
wdt:P50
wd:Q60320900 wd:Q66370907 wd:Q114427991 wd:Q114427994 wd:Q53342434 wd:Q60394812 wd:Q114427992 wd:Q37829812
p:P1476
wds:Q37427140-87C6762A-64BC-4AD4-BEA2-7AD6F5AB711E
wdt:P1476
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
p:P304
wds:Q37427140-50BC4B26-6E70-46E9-BFF2-46BC87DB03AD
wdt:P304
2333-2340
p:P31
wds:Q37427140-FDE7C6BA-D3D3-4A28-AD02-6D3A4C16E34B
wdt:P31
wd:Q13442814
p:P921
wds:Q37427140-5CE09963-F6AA-431B-A43A-CD4715A6DB45 wds:Q37427140-D9DD54FF-7C9C-45FC-A83D-239E058496A9 wds:Q37427140-11F93C57-0AF8-4AA2-BAB4-EBB20A9EF93A wds:Q37427140-2627861A-8532-4A7D-B4D4-A51B96E95B03 wds:Q37427140-52DFDD49-20F2-440C-BEAF-2AC304ADB31F wds:Q37427140-5CC1CAB1-6B5E-47DC-B4D3-A2A8D553B36E
wdt:P921
wd:Q177094 wd:Q29496 wd:Q419940 wd:Q729735 wd:Q181600 wd:Q27139135
p:P698
wds:Q37427140-63DF6C84-91EE-4F2D-9FA6-C877D0C2A67B
wdtn:P698
n11:27217448
wdt:P698
27217448
p:P1433
wds:Q37427140-B8C26063-916E-472F-A2D6-00063EFF1982
wdt:P1433
wd:Q400292
p:P433
wds:Q37427140-8E06FECC-78A9-49C3-A55D-7AF83769C9B2
p:P478
wds:Q37427140-E43FB1C8-00CF-4526-A020-E13A3BAA6B1A
wdt:P433
20
wdt:P478
34
p:P356
wds:Q37427140-60F542E9-D02F-4B13-AD70-8C75F1DF02EC
wdtn:P356
n12:JCO.2015.64.8899
wdt:P356
10.1200/JCO.2015.64.8899
p:P932
wds:Q37427140-45EE2DD5-FE28-418D-9DE8-FC675A468570
wdt:P932
5118045